The goal to find the most efficient, cost effective and sustainable processing technologies continues to be at the forefront of the biopharmaceutical and pharmaceutical industry, and in response has seen the unveiling of EnzeneX(TM) 2.0. Chloe Euripides and Kelly Woods of the International Biopharmaceutical Industry Journal sat down with Dr. Himanshu Gadgil and Russell Miller of Enzene, to hear all things EnzeneX(TM) 2.0, their new innovative technology that ensures fully-connected continuous manufacturing, from perfusion to the final drug substance.